Schedule 13D ownership disclosure

EVOKE PHARMA INC

Common Stock, par value $0.0001 per share · CUSIP: 30049G302

Event date: 2025-11-04

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Klein Roger M.Reported CIK 0001651175

    Shares: 163,000.00 · Class: 10.5%

  • Krieger Charitable Trust

    Shares: 129,000.00 · Class: 8.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001651175-25-000007
Form type
SCHEDULE 13D
Filer
Evoke Pharma Inc
CIK
CIK 1403708
Filed
Nov 12, 2025
Reporting period
Nov 04, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub